C-abl upregulates the transcriptional activity of ERβ by their interaction

Progress in Biochemistry and Biophysics

Volumn 37, Issue 1, 2010, Pages 74-78

  Gao, Yuan ^a   Chen, Xuan Nan ^b,c   Wei, Cong Wen ^d   Zheng, Zi Rui ^d   Ma, Hong Fang ^d   Ni, Cai Fei ^d   Song, Ting ^d   Qi, Guo Xian ^a   Zhong, Hui ^d   He, Xiang ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c JILIN UNIVERSITY   (China)

^d BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

C abl; Cardiovascular disease; Estrogen receptor ; Protein protein interaction

Indexed keywords

EID: 77952013608     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00466     Document Type: Article

References (12)

1. Zhu Y, Bian Z, Lu P, et al. Abnormal vascular functionand hypertension in mice deficient in estrogen receptor β. Science, 2002, 295(5554): 505-508
2. Skavdahl M, Clark J, Murphy E, et al. Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol, 2005, 288 (2): H469-476 (Pubitemid 40139627)
3. Wang M, Wang Y, Weil B, et al. Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol, 2009, 296(4): 972-978
4. Ellis J A, Infantino T, Harrap S B. Sex-dependent association of blood pressure with oestrogen eceptor genes ERa and ERb. J Hypertens, 2004, 22(6): 1127-1131 (Pubitemid 38721004)
5. Arias-Loza P A, Jazbutyte V, Pelzer T. Genetic and pharmacologic strategies to determine the function of estrogen receptor alpha and estrogen receptor beta in cardiovascular system. Gend Med, 2008, 5(Suppl A): S34-45 (Pubitemid 351455230)
6. Babiker F A, Lips D, Meyer R, et al. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vase Biol, 2006, 26(7): 1524-1530 (Pubitemid 44288978)
7. Liu X, Huang W, Li C, et al. Nteraction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation. Mol Cell, 2006, 22(3): 317-327
8. Wang X H, Zhang H, Zhou L, et al. Chin J Biochem Mol Biol, 2006, 22(5): 384-389
9. Ushio-Fukai M, Zuo L, Ikeda S, et al. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent ATI receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Circ Res, 2005, 97(8): 829-836
10. Kimura S, Egashira K, Nakano K, et al. Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation. Circulation, 2008, 118(14 Suppl): S65-70
11. Bregeon J, Loirand G, Pacaud P, et al. Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p 190A in vascular smooth muscle cells. Am J Physiol Cell Physiol, 2009,297(5): C1062-1070
12. Kerkela R, Grazette L, Yacobi R, et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med, 2006, 12(8): 908-916